← 產業報告目錄
Lipid Nanoparticle Raw Materials Market Size, Share & Trends Analysis Report, By Application (Therapeutics and Research), By Product (Kits, Reagents, Others), By Disease Indication (Cancer, Infectious Diseases, Blood Diseases, Others), By End User (Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, Others), By Region, Forecasts, 2025-2034
出版商 InsightAce Analytic產業別 Healthcare & Life Sciences出版日期 2026-01-06頁數 180報告編號 INSIGHTACE-9b8bf3a1b0
授權報價
| Single User PDF | $4,500 USD |
| Global Site License PDF | $9,500 USD |
報告摘要
The worldwide Lipid Nanoparticle Raw Materials Market stood at USD 239.4 Mn in 2024, and is poised to reach USD 421.2 Mn by 2034, recording a CAGR of 6.0% from 2025 through 2034.
At its core, Lipid Nanoparticle Raw Materials pertains to landscape are expandingly turning to these solutions to meet contemporary demands.
The market's upward path is fueled by expanding healthcare spending, technological evolution, and the expanding focus on personalized and precision-based approaches in healthcare.
Segmental analysis reveals differentiated growth across product categories, applications, and geographical regions, with certain niches demonstrating above-average expansion potential.
Geographically, North America maintains a leading position owing to advanced infrastructure, high R&D expenditure, and a well-established regulatory environment. Meanwhile, Asia-Pacific is emerging as the fastest-growing region, fueled by rapid industrialization and expanding end-user bases.
Competition in this space is characterized by active product development, strategic collaborations, and geographic expansion among both global leaders and specialized niche players.
The research provides an in-depth evaluation of market forces, competitive positioning, segmental dynamics, and regional trends, equipping stakeholders with actionable intelligence for the forecast period.
目錄 Table of Contents
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Lipid Nanoparticle Raw Materials Market Snapshot
Chapter 4. Global Lipid Nanoparticle Raw Materials Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis – Porter's Five Forces Analysis
4.7. Competitive Landscape & Market Share Analysis
4.8. Impact of Covid-19 Analysis
Chapter 5. Market Segmentation 1: by Application Estimates & Trend Analysis
5.1. by Application & Market Share, 2024 & 2034
5.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2021 to 2034 for the following by Application:
5.2.1. Therapeutics
5.2.2. Research
Chapter 6. Market Segmentation 2: by Product Estimates & Trend Analysis
6.1. by Product & Market Share, 2024 & 2034
6.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2021 to 2034 for the following by Product:
6.2.1 Kits
6.2.1.1 Ionizable Lipids
6.2.1.2 PEGylated Lipids
6.2.1.3 Sterol Lipids
6.2.1.4 Neutral Phospholipids
6.2.2 Reagents
6.2.3 Other Raw Materials
Chapter 7. Market Segmentation 3: by Disease Indication Estimates & Trend Analysis
7.1. by Disease Indication & Market Share, 2024 & 2034
7.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2021 to 2034 for the following by Disease Indication:
7.2.1. Cancer
7.2.2. Infectious Diseases
7.2.3. Blood Diseases
7.2.4. Others
Chapter 8. Market Segmentation 4: by End-Use Estimates & Trend Analysis
8.1. by End-Use & Market Share, 2024 & 2034
8.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2021 to 2034 for the following by End-Use:
8.2.1. Pharmaceutical & Biotechnology Companies
8.2.2. Academic & Research Institutes
8.2.3. Others
Chapter 9. Lipid Nanoparticle Raw Materials Market Segmentation 6: Regional Estimates & Trend Analysis
9.1. North America
9.1.1. North America Lipid Nanoparticle Raw Materials Market Revenue (US$ Million) Estimates and Forecasts by Application, 2021-2034
9.1.2. North America Lipid Nanoparticle Raw Materials Market Revenue (US$ Million) Estimates and Forecasts by Product, 2021-2034
9.1.3. North America Lipid Nanoparticle Raw Materials Market Revenue (US$ Million) Estimates and Forecasts by Disease Indication, 2021-2034
9.1.4. North America Lipid Nanoparticle Raw Materials Market Revenue (US$ Million) Estimates and Forecasts by End-Use, 2021-2034
9.1.5. North America Lipid Nanoparticle Raw Materials Market Revenue (US$ Million) Estimates and Forecasts by country, 2021-2034
9.2. Europe
9.2.1. Europe Lipid Nanoparticle Raw Materials Market Revenue (US$ Million) Estimates and Forecasts by Application, 2021-2034
9.2.2. Europe Lipid Nanoparticle Raw Materials Market Revenue (US$ Million) Estimates and Forecasts by Product, 2021-2034
9.2.3. Europe Lipid Nanoparticle Raw Materials Market Revenue (US$ Million) Estimates and Forecasts by Disease Indication, 2021-2034
9.2.4. Europe Lipid Nanoparticle Raw Materials Market Revenue (US$ Million) Estimates and Forecasts by End-Use, 2021-2034
9.2.5. Europe Lipid Nanoparticle Raw Materials Market Revenue (US$ Million) Estimates and Forecasts by country, 2021-2034
9.3. Asia Pacific
9.3.1. Asia Pacific Lipid Nanoparticle Raw Materials Market Revenue (US$ Million) Estimates and Forecasts by Application, 2021-2034
9.3.2. Asia Pacific Lipid Nanoparticle Raw Materials Market Revenue (US$ Million) Estimates and Forecasts by Product, 2021-2034
9.3.3. Asia-Pacific Lipid Nanoparticle Raw Materials Market Revenue (US$ Million) Estimates and Forecasts by Disease Indication, 2021-2034
9.3.4. Asia Pacific Lipid Nanoparticle Raw Materials Market Revenue (US$ Million) Estimates and Forecasts by End-Use, 2021-2034
9.3.5. Asia Pacific Lipid Nanoparticle Raw Materials Market Revenue (US$ Million) Estimates and Forecasts by country, 2021-2034
9.4. Latin America
9.4.1. Latin America Lipid Nanoparticle Raw Materials Market Revenue (US$ Million) Estimates and Forecasts by Application, 2021-2034
9.4.2. Latin America Lipid Nanoparticle Raw Materials Market Revenue (US$ Million) Estimates and Forecasts by Product, 2021-2034
9.4.3. Latin America Lipid Nanoparticle Raw Materials Market Revenue (US$ Million) Estimates and Forecasts by Disease Indication, 2021-2034
9.4.4. Latin America Lipid Nanoparticle Raw Materials Market Revenue (US$ Million) Estimates and Forecasts by End-Use, 2021-2034
9.4.5. Latin America Lipid Nanoparticle Raw Materials Market Revenue (US$ Million) Estimates and Forecasts by country, 2021-2034
9.5. Middle East & Africa
9.5.1. Middle East & Africa Lipid Nanoparticle Raw Materials Market Revenue (US$ Million) Estimates and Forecasts by Application, 2021-2034
9.5.2. Middle East & Africa Lipid Nanoparticle Raw Materials Market Revenue (US$ Million) Estimates and Forecasts by Product, 2021-2034
9.5.3. Middle East & Africa Lipid Nanoparticle Raw Materials Market Revenue (US$ Million) Estimates and Forecasts by Disease Indication, 2021-2034
9.5.4. Middle East & Africa Lipid Nanoparticle Raw Materials Market Revenue (US$ Million) Estimates and Forecasts by End-Use, 2021-2034
9.5.5. Middle East & Africa Lipid Nanoparticle Raw Materials Market Revenue (US$ Million) Estimates and Forecasts by country, 2021-2034
Chapter 10. Competitive Landscape
10.1. Major Mergers and Acquisitions/Strategic Alliances
10.2. Company Profiles
10.2.1. Merck KGaA
10.2.2. Echelon Biosciences
10.2.3. BroadPharm
10.2.4. Avanti Polar Lipids
10.2.5. Tebubio
10.2.6. CordenPharma International
10.2.7. Creative Biolabs
10.2.8. Biopharma PEG Scientific Inc.
10.2.9. NOF AMERICA CORPORATION
10.2.10. Polysciences, Inc.
量子訊息有限公司為 InsightAce Analytic 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們